[Antitumor effect of pirarubicin (THP) against human colon cancer transplanted into nude mice and the mechanism of cell cycle progression]. 1992

K Kataoka, and Y Naomoto, and M Muro, and K Kojima, and S Horiki, and A Hizuta, and N Tanaka, and K Orita
First Dept. of Surgery, Okayama University Medical School.

Pirarubicin (THP) is a derivative of adriamycin (ADM) which has been reported to have a lower cardiotoxicity than ADM. The authors investigated the in vivo antitumor effect of THP against human colon cancer cells (RPMI 4788) xenografted into nude mice. In the model of intra-abdominal carcinomatosis, intraperitoneal administration of THP (6 mg/kg) resulted in a significant prolongation of the survival compared with the saline control group (p less than 0.01). Intravenous administration of THP (8 mg/kg) significantly inhibited tumor growth compared with the saline control group. Labeling index with bromodeoxyuridine (BrdU) of RPMI 4788 tumors treated with THP was smaller than that in the control group. Mitotic index was also smaller in the group treated with THP. Labeling index with BrdU indicates the proportion of cells in the S phase. Thus, the tumor cells in both S and M phases have decreased after treatment with THP. This change in the cell cycle progression may be due to the accumulation of G2 phase similar to in vitro study. From these results, it was suggested that the change in cell cycle progression revealed in vitro might be caused by THP in vivo.

UI MeSH Term Description Entries
D008297 Male Males
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

K Kataoka, and Y Naomoto, and M Muro, and K Kojima, and S Horiki, and A Hizuta, and N Tanaka, and K Orita
December 1984, Journal of pharmacobio-dynamics,
K Kataoka, and Y Naomoto, and M Muro, and K Kojima, and S Horiki, and A Hizuta, and N Tanaka, and K Orita
November 1986, Journal of pharmacobio-dynamics,
K Kataoka, and Y Naomoto, and M Muro, and K Kojima, and S Horiki, and A Hizuta, and N Tanaka, and K Orita
November 1983, European journal of cancer & clinical oncology,
K Kataoka, and Y Naomoto, and M Muro, and K Kojima, and S Horiki, and A Hizuta, and N Tanaka, and K Orita
January 1987, Acta obstetricia et gynecologica Scandinavica,
K Kataoka, and Y Naomoto, and M Muro, and K Kojima, and S Horiki, and A Hizuta, and N Tanaka, and K Orita
February 1997, Journal of surgical oncology,
K Kataoka, and Y Naomoto, and M Muro, and K Kojima, and S Horiki, and A Hizuta, and N Tanaka, and K Orita
October 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
K Kataoka, and Y Naomoto, and M Muro, and K Kojima, and S Horiki, and A Hizuta, and N Tanaka, and K Orita
June 1991, Immunology and cell biology,
K Kataoka, and Y Naomoto, and M Muro, and K Kojima, and S Horiki, and A Hizuta, and N Tanaka, and K Orita
August 1989, Acta medica Okayama,
K Kataoka, and Y Naomoto, and M Muro, and K Kojima, and S Horiki, and A Hizuta, and N Tanaka, and K Orita
February 1986, Nihon Gan Chiryo Gakkai shi,
K Kataoka, and Y Naomoto, and M Muro, and K Kojima, and S Horiki, and A Hizuta, and N Tanaka, and K Orita
January 1987, The Japanese journal of surgery,
Copied contents to your clipboard!